Last Price
25.75
Today's Change
+0.02 (0.07%)
Day's Change
25.55 - 26.13
Trading Volume
2,112,959
Exchange: New York Stock Exchange New York Stock Exchange
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Patrick Lockwood-Taylor Mr. Patrick Lockwood-Taylor
Full Time Employees: 9,140 9,140
IPO Date: 1991-12-17 1991-12-17
CIK: 0001585364 0001585364
ISIN: IE00BGH1M568 IE00BGH1M568
CUSIP: G97822103 G97822103
Beta: 0.48 0.48
Last Dividend: 1.10 1.10
Dcf Diff: -55.20 -55.20
Dcf: 82.95 82.95
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.